Mitchell J. Geer

NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Also affiliated with New York University

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition”.

Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition

The Journal of Experimental Medicine(2023)10.1084/jem.20221563

N/A

0.500DataRank · unranked

27 citations

Mitchell J. Geer, Xinyi Guo, Igor Dolgalev, Neville E. Sanjana, Benjamin G. Neel +1 more

SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling

The Journal of Experimental Medicine(2020)10.1084/jem.20201414

N/A

0DataRank · unranked

259 citations

Shuai Li, Kai Wen Teng, Connor Foster, David H. Peng, Hao Ran +18 more

T Lymphocyte-Specific Deletion of SHP1 and SHP2 Promotes Activation-Induced Cell Death of CD4+ T Cells and Impairs Antitumor Response

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.03.631277

N/A

0DataRank · unranked

1 citations

Jasper Du, Oscar J. Pundel, Mitchell J. Geer, Ryan C. Ripert, Jia Liu +6 more